A similar result was observed in the study of hepatocellular carcinoma (HCC) conducted by Xiao et al. that stromal CD74+ macrophages enrichment was associated with favorable prognosis in patients with HCC [47]. The gene discussed is CD74; the disease is hepatocellular carcinoma.